Top Medical News

Ultraprocessed Food Consumption Association With Increased Risk of Cognitive Decline

December 08, 2022

By Marco Meglio

Percentage of daily energy from ultraprocessed food was associated with cognitive decline in participants younger than 60 years, suggesting the importance of preventive interventions in middle-aged adults.

Behavioral Treatment for Insomnia Shows Short-Term Potential to Improve Trauma-Related Nightmares

December 08, 2022

By Marco Meglio

More than half of the patients who reported at least 1 trauma-related nightmare showed decreases after starting brief behavioral treatment.

Fenfluramine Continues to Show Effectiveness, Safety in Long-Term Analysis of Lennox-Gastaut

December 07, 2022

By Marco Meglio

After nearly a year of treatment with fenfluramine, more than half of patients with Lennox-Gastaut syndrome demonstrated at least a 50% reduction in drop seizure frequency.

Strong Communication on Seizure Management Leads to Improved Care in Dravet Syndrome

December 07, 2022

By Isabella Ciccone, MPH

A qualitative study presented at the 2022 AES annual meeting showed that effective communication between clinicians and caregivers of patients with dravet syndrome improves care.

NeuroVoices: Sube Banerjee, MD, MSc, MBA, FRCPsych, on Replacing Traditional Noneffective Agents for Alzheimer Agitation

December 07, 2022

By Marco Meglio

The professor of dementia and executive dean of the Faculty of Health at the University of Plymouth provided perspective on the SYMBAD trial, and eliminating the use of mirtazapine and carbamazepine as medications to treat Alzheimer agitation.

Featured

Latest Videos

Access and Treatment of Insomnia in Primary Care Clinics

Long-Term Safety of S1P Receptor Modulators in Multiple Sclerosis

Comparing Reactive Microglia and Astrocytes in Secondary Progressive Multiple Sclerosis

Therapeutic Potential of ALZ-801 in High-Risk Alzheimer Disease: Susan Abushakra, MD

Assessing Response to Insomnia Treatment

Phase 3 Studies on Daridorexant for Treatment of Sleep Disorders

Bridging the Gap of Knowledge in Early Onset Epilepsy to Optimize Clinical Care: Zachary Grinspan, MD, MS

Reimaging the Approach to Treating Alzheimer Agitation: Sube Banerjee, MD, MSc, MBA, FRCPsych

Expanding the Pathways to Treat Dementia With Lewy Bodies: James Galvin, MD, MPH

Working Towards Lowering ARIA Rates, Reducing Amyloid Plaques: Marwan Sabbagh, MD, FAAN

More Awareness Needed for Sleep Health and Pediatric Epilepsy: Renee Shellhaas, MD, MS, FAES

Brain Health in Multiple Sclerosis

Clinician and Patient Collaboration Advances Research and Epilepsy Care: Colin Josephson, MD, MSc, FRCPC

Most Recent

Raising the Overall Awareness for Infantile Spasms, Early Recognition of Pre-Epilepsy Diagnosis

December 06, 2022

Article

Martina Bebin, MD, MPA, professor of neurology, University of Alabama at Birmingham Epilepsy Center, discussed Infantile Spasms Awareness Week, the strides made within the field, and the emphasis on early and accurate diagnosis.

DNL343 to be Assessed in HEALEY ALS Platform Trial Following Positive Phase 1 Findings

December 06, 2022

Article

After showing robust inhibition of biomarkers associated with integrated stress response, the eIF28 modulator will be assessed alongside several other potential agents in the HEALEY ALS Platform trial.

Chronic ASM Use Associated With Acute Symptomatic Seizures in Patients With Stroke

December 06, 2022

Article

Retrospective analysis of a group of individuals with stroke suggests that nonconvulsive acute symptomatic seizures are associated with long-term use of antiseizure medications, providing key data in guiding therapy use in this population.

The Advantages of Multidisciplinary Care and APP Incorporation in Epilepsy

December 06, 2022

Article

Lucretia Long, APRN-CNP, an associate clinical professor of neurology at OSU Wexner Medical Center, offered her perspective on the benefits of having multiple specialists available to provide comprehensive care to patients.

Cenobamate Not Associated With Clinically Significant Weight Change in Epilepsy Treatment

December 06, 2022

Article

Notably, though, cenobamate treatment was associated with weight reductions among patients who were categorized as overweight and obese, but not in those who were underweight or normal weight.

Expensive Antiseizure Medications Cause for Concern for Patients with Epilepsy: Deepti Zutshi, MD, FAAN

December 05, 2022

Video

The associate professor of neurology at Wayne State University in Detroit, Michigan, spoke about expensive antiseizure medications for epilepsy along with spending for Medicare and Medicaid at the 2022 AES Annual Meeting. [WATCH TIME: 4 minutes]

XEN1101 Posts Positive Efficacy, Safety in Focal-Onset Epilepsy in Interim Phase 2b Open-Label Data

December 05, 2022

Article

The investigational therapy from Xenon Pharmaceuticals showed marked reductions in monthly seizure frequency from months 14 to 20, with consistent safety and good retention rates.

Growing the Knowledge of Detection and Treatment of Infantile Spasms: Martina Bebin, MD, MPA

December 05, 2022

Video

The professor of neurology and pediatrics at the University of Alabama at Birmingham Epilepsy Center provided perspective on the strides made with detection and treatment of infantile spasms. [WATCH TIME: 3 minutes]

This Week on NeurologyLive® — December 5, 2022

December 05, 2022

Article

Here's some of what is coming soon to NeurologyLive® this week.

Jacksonian Epilepsy and the Jacksonian March: R. Edward Hogan, MD

December 05, 2022

Video

The professor of neurology at Washington University in St. Louis, and the president of the American Epilepsy Society, shared his perspective on John Hughlings Jackson’s observations of epilepsy in the brain and how it can inform modern practice. [WATCH TIME: 5 minutes]

Latest SAP Content

Fenfluramine Continues to Show Effectiveness, Safety in Long-Term Analysis of Lennox-Gastaut

Expanding the Pathways to Treat Dementia With Lewy Bodies: James Galvin, MD, MPH

Raising the Overall Awareness for Infantile Spasms, Early Recognition of Pre-Epilepsy Diagnosis

Chronic ASM Use Associated With Acute Symptomatic Seizures in Patients With Stroke

View More SAP Content